Search research articles
Contact Us
Filters
Showing results (81-90 of 635) with videos related to
Page
of 64
Sort By:
Clinical and Experimental Immunology
|
March 1, 1978
Haptenic antibody induced by N-phthaloylated ox insulin in the Hartley guinea-pig
P J Hollins, M M Nathan
Annals of Internal Medicine
|
May 6, 2004
Screening for diabetes: can we afford not to screen?
David M Nathan, William H Herman
Journal of Opioid Management
|
February 27, 2007
Methadone in end-of-life pain management
Diane L Chau, M Nathan Mason
Surgical Neurology International
|
May 30, 2013
Surgery for brain metastases
Kurt Andrew Yaeger, M Nathan Nair
Oral and Maxillofacial Surgery Clinics of North America
|
June 5, 2021
Management of Nasal Trauma
John M Nathan, Kyle S Ettinger
Clinical and Experimental Immunology
|
October 1, 1979
Alteration in the immunochemical dominance of determinants following the chemical modification of ox insulins: implications for the structure of the ox insulin monomer in solution
P J Hollins, M M Nathan
Journal of the American Dietetic Association
|
November 27, 2004
Research navigating the course of clinical practice in diabetes
Linda M Delahanty, David M Nathan
Diabetes Care
|
September 22, 2021
Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC)
John M Lachin, David M Nathan,
Ophthalmology
|
August 24, 2016
Preventing Diabetic Retinopathy Progression
Frederick L Ferris, David M Nathan
Critical Care Nursing Quarterly
|
May 13, 2004
Point-of-care testing for diabetes
Deirdre R Blake, David M Nathan
Page
of 64
Search research articles
Search
Showing results (81-90 of 635) with videos related to
Sort By:
Page
of 64
Clinical and Experimental Immunology
|
March 1, 1978
Haptenic antibody induced by N-phthaloylated ox insulin in the Hartley guinea-pig
P J Hollins, M M Nathan
Annals of Internal Medicine
|
May 6, 2004
Screening for diabetes: can we afford not to screen?
David M Nathan, William H Herman
Journal of Opioid Management
|
February 27, 2007
Methadone in end-of-life pain management
Diane L Chau, M Nathan Mason
Surgical Neurology International
|
May 30, 2013
Surgery for brain metastases
Kurt Andrew Yaeger, M Nathan Nair
Oral and Maxillofacial Surgery Clinics of North America
|
June 5, 2021
Management of Nasal Trauma
John M Nathan, Kyle S Ettinger
Clinical and Experimental Immunology
|
October 1, 1979
Alteration in the immunochemical dominance of determinants following the chemical modification of ox insulins: implications for the structure of the ox insulin monomer in solution
P J Hollins, M M Nathan
Journal of the American Dietetic Association
|
November 27, 2004
Research navigating the course of clinical practice in diabetes
Linda M Delahanty, David M Nathan
Diabetes Care
|
September 22, 2021
Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC)
John M Lachin, David M Nathan,
Ophthalmology
|
August 24, 2016
Preventing Diabetic Retinopathy Progression
Frederick L Ferris, David M Nathan
Critical Care Nursing Quarterly
|
May 13, 2004
Point-of-care testing for diabetes
Deirdre R Blake, David M Nathan
Page
of 64